(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 149.83%656.71M | ---- | -54.21%262.86M | ---- | 32.57%574.12M | ---- | -64.63%433.06M | ---- | 48.89%1.22B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -69.17%-37.62M | ---- | 20.81%-22.24M | ---- | -49.57%-28.08M | ---- | -125.23%-18.77M | ---- | -33.15%-8.34M |
Interest expense - adjustment | ---- | -44.63%92.34M | ---- | -17.83%166.76M | ---- | -19.42%202.93M | ---- | 1.74%251.83M | ---- | 65.19%247.52M |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -334.18%-851K | ---- | 65.12%-196K |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | 1,164.25%163.51M | ---- | -1,333.21%-15.36M | ---- | -215.39%-1.07M |
Impairment and provisions: | ---- | -140.55%-41.35M | ---- | 160.30%101.96M | ---- | 380.49%39.17M | ---- | 64.53%-13.97M | ---- | -12.68%-39.37M |
-Impairment of property, plant and equipment (reversal) | ---- | 38.91%27.78M | ---- | --20M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | -203.77%-78.88M | ---- | 134.22%76.02M | ---- | 234.35%32.46M | ---- | 60.42%-24.16M | ---- | 2.50%-61.03M |
-Impairment of trade receivables (reversal) | ---- | 46.67%8.89M | ---- | --6.06M | ---- | ---- | ---- | -104.97%-584K | ---- | 0.29%11.74M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.17M | ---- | ---- |
-Other impairments and provisions | ---- | 791.94%858K | ---- | -101.85%-124K | ---- | 1,786.93%6.71M | ---- | -104.01%-398K | ---- | -37.82%9.91M |
Revaluation surplus: | ---- | 1,936.00%24.43M | ---- | -79.31%1.2M | ---- | --5.8M | ---- | ---- | ---- | ---- |
-Fair value of investment properties (increase) | ---- | 1,966.67%24.8M | ---- | -79.31%1.2M | ---- | --5.8M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---368K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | -7.12%29.71M | ---- | -23.79%31.99M | ---- | -15.90%41.97M | ---- | -2.68%49.91M | ---- | 4.09%51.29M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | --5.94M | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 14.08%29.71M | ---- | -37.95%26.05M | ---- | -15.90%41.97M | ---- | -2.68%49.91M | ---- | 6.79%51.29M |
Depreciation and amortization: | ---- | -20.19%1.26B | ---- | -16.13%1.57B | ---- | 2.65%1.88B | ---- | 24.47%1.83B | ---- | 189.32%1.47B |
-Depreciation | ---- | -24.50%363.64M | ---- | -10.92%481.65M | ---- | -0.09%540.67M | ---- | 14.23%541.14M | ---- | 23.56%473.73M |
-Amortization of intangible assets | ---- | 7.45%9.07M | ---- | -91.55%8.44M | ---- | -2.96%99.91M | ---- | -1.82%102.97M | ---- | -15.32%104.88M |
Special items | ---- | -27.64%2.44M | ---- | -38.80%3.38M | ---- | 385.01%5.52M | ---- | -109.77%-1.94M | ---- | 12.57%19.81M |
Operating profit before the change of operating capital | ---- | -6.45%1.98B | ---- | -26.44%2.12B | ---- | 14.72%2.88B | ---- | -15.23%2.51B | ---- | 96.72%2.96B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 15.74%1.45B | ---- | 234.78%1.25B | ---- | -142.60%-927.03M | ---- | 272.21%2.18B | ---- | -21.25%-1.26B |
Accounts receivable (increase)decrease | ---- | -141.10%-139.44M | ---- | -60.08%339.27M | ---- | 505.33%849.83M | ---- | -19.00%-209.66M | ---- | 61.99%-176.18M |
Accounts payable increase (decrease) | ---- | 127.14%307.93M | ---- | -869.62%-1.13B | ---- | -118.33%-117.02M | ---- | 9.30%638.27M | ---- | 86.65%583.98M |
prepayments (increase)decrease | ---- | -39.12%158.29M | ---- | 196.72%260.02M | ---- | -358.84%-268.84M | ---- | 2,672.66%103.86M | ---- | 112.52%3.75M |
Special items for working capital changes | ---- | -6,446.39%-144.19M | ---- | 101.62%2.27M | ---- | -182.05%-140.22M | ---- | 4,795.27%170.89M | ---- | 109.50%3.49M |
Cash from business operations | ---- | 27.36%3.61B | ---- | 24.51%2.83B | ---- | -57.76%2.28B | ---- | 155.08%5.39B | ---- | 758.67%2.11B |
Other taxs | ---- | -22.46%-206.3M | ---- | 61.67%-168.46M | ---- | -62.32%-439.56M | ---- | 5.19%-270.81M | ---- | -13.23%-285.64M |
Special items of business | -56.79%873.31M | ---- | 523.59%2.02B | ---- | -67.24%324.08M | ---- | -63.62%989.35M | ---- | 192.32%2.72B | ---- |
Net cash from operations | -56.79%873.31M | 27.67%3.4B | 523.59%2.02B | 45.13%2.67B | -67.24%324.08M | -64.11%1.84B | -63.62%989.35M | 180.13%5.12B | 192.32%2.72B | 29,747.42%1.83B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 95.89%27.74M | 69.17%37.62M | 33.79%14.16M | -20.81%22.24M | -27.30%10.58M | 49.57%28.08M | 112.08%14.56M | 125.23%18.77M | 60.15%6.86M | 33.15%8.34M |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 334.18%851K | 344.27%853K | -65.12%196K |
Loan receivable (increase) decrease | ---- | ---- | ---- | --34M | --0 | --0 | --0 | -2,442.07%-263.49M | --0 | -361.21%-10.37M |
Decrease in deposits (increase) | -125.00%-450M | ---1.05B | ---200M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | -0.20%3.01M | -60.17%4.56M | -64.20%3.01M | 115.12%11.44M | 44.11%8.41M | -76.35%5.32M | -34.94%5.84M | -4.17%22.48M | 2.78%8.97M | 63.81%23.46M |
Purchase of fixed assets | -16.37%-183.03M | 0.18%-311.08M | -9.37%-157.28M | 31.12%-311.64M | 35.67%-143.81M | 22.67%-452.4M | -36.89%-223.53M | 27.52%-585.03M | ---163.3M | -51.80%-807.13M |
Purchase of intangible assets | 27.85%-10.58M | -277.91%-38.04M | -627.27%-14.67M | 55.02%-10.07M | 74.35%-2.02M | -1.93%-22.38M | 48.86%-7.87M | -62.12%-21.95M | ---15.38M | ---13.54M |
Sale of subsidiaries | ---- | ---- | ---- | --3.83M | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --9.46M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 321.88%128.19M | ---- | 9.33%30.39M | ---- | 79.26%27.79M | -67.91%15.51M | 72.26%15.5M | -90.88%48.34M | --9M |
Cash on investment | ---- | ---89.92M | ---- | ---- | ---- | ---- | ---- | 83.09%-161.96M | 80.50%-160M | -72.62%-958.06M |
Other items in the investment business | -78.18%4.82M | ---- | 31.73%22.07M | ---- | --16.76M | ---- | ---- | -94.44%50M | ---- | 62.16%900M |
Net cash from investment operations | -82.76%-608.06M | -498.35%-1.32B | -202.25%-332.7M | 45.61%-219.82M | 43.69%-110.08M | 56.30%-404.14M | 28.56%-195.49M | -9.05%-924.83M | 5.15%-273.65M | -67.42%-848.11M |
Net cash before financing | -84.29%265.25M | -14.62%2.09B | 688.87%1.69B | 70.71%2.45B | -73.04%214.01M | -65.83%1.43B | -67.54%793.86M | 328.29%4.19B | 281.10%2.45B | 291.00%979.36M |
Cash flow from financing activities | ||||||||||
New borrowing | -34.50%276.74M | -74.64%524.8M | -78.12%422.49M | -0.69%2.07B | 52.16%1.93B | -37.80%2.08B | -41.11%1.27B | -34.06%3.35B | -16.32%2.15B | -29.15%5.08B |
Refund | 64.88%-276.96M | 70.49%-942.49M | 44.08%-788.7M | -22.83%-3.19B | -8.35%-1.41B | 47.44%-2.6B | 56.03%-1.3B | 2.39%-4.95B | -4.23%-2.96B | 17.88%-5.07B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.09%348K | -97.09%348K | 67.96%11.96M |
Interest paid - financing | 81.71%-1.22M | 87.34%-8.18M | 81.78%-6.68M | 6.77%-64.59M | 1.60%-36.67M | 45.36%-69.28M | 50.39%-37.27M | 5.56%-126.79M | -16.56%-75.12M | 10.40%-134.25M |
Dividends paid - financing | ---56.65M | 15.82%-87.88M | ---- | -272.88%-104.41M | ---70.81M | ---28M | ---- | ---- | ---- | -48.14%-129.33M |
Absorb investment income | --1.4M | ---- | ---- | ---- | ---- | --3.5M | --3.5M | ---- | ---- | -5.01%92.5M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---30.36M | ---- | ---- | ---- | ---- |
Other items of the financing business | 11.37%-425.78M | 21.59%-936.99M | 21.88%-480.43M | 8.14%-1.19B | 9.49%-615.01M | 3.19%-1.3B | -20.32%-679.48M | -41.36%-1.34B | -50.38%-564.74M | ---950.56M |
Net cash from financing operations | 43.46%-482.48M | 41.69%-1.45B | -322.17%-853.31M | -28.16%-2.49B | 72.91%-202.13M | 36.71%-1.94B | 48.37%-746.03M | -179.36%-3.07B | -97.30%-1.45B | -226.88%-1.1B |
Effect of rate | 986.98%1.5M | 67.43%-708K | 90.00%-169K | -601.29%-2.17M | -610.08%-1.69M | -119.45%-310K | -112.63%-238K | 24.73%1.59M | 97.80%1.89M | 33.82%1.28M |
Net Cash | -126.02%-217.23M | 1,639.09%638.12M | 6,927.51%834.94M | 91.84%-41.46M | -75.16%11.88M | -145.09%-508.2M | -95.22%47.83M | 1,050.00%1.13B | 1,203.68%1B | -133.65%-118.64M |
Begining period cash | 53.56%1.83B | -3.54%1.19B | -3.54%1.19B | -29.19%1.23B | -29.19%1.23B | 183.95%1.74B | 183.95%1.74B | -16.06%613.59M | -16.06%613.59M | 93.69%730.96M |
Cash at the end | -20.40%1.61B | 53.56%1.83B | 62.78%2.02B | -3.54%1.19B | -30.50%1.24B | -29.19%1.23B | 10.75%1.79B | 183.95%1.74B | 152.04%1.62B | -16.06%613.59M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 183.95%1.74B | ---- | --613.59M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 183.95%1.74B | ---- | --613.59M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data